Thus, there must be some molecular regulators that play a vital role in the tumorigenesis of SCLC, in addition to the loss of TP53 and RB1. Clearly, identification of these initial factors is urgently needed to bring breakthroughs to the prognosis assessment and treatment of SCLC. This evidence concerns the gene RB1 and small cell lung carcinoma.